Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Robo Global Healthcare Technology and Innovation ETF (HTEC) belongs to the Multiple Trends segment. Invesco Dynamic Biotechnology & Genome ETF (PBE) is part of the BioTech & Genomics segment. HTEC's top 3 sector exposures are Health Care, Consumer Discretionary and Information Technology. In contrast, PBE's top sector exposures are Health Care, HTEC is more expensive with a Total Expense Ratio (TER) of 0.8%, versus 0.58% for PBE. HTEC is down -5.19% year-to-date (YTD) with - in YTD flows. PBE performs worse with -7.12% YTD performance, and +$135K in YTD flows. Run a side-by-side ETF comparison of HTEC and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | HTEC PBE | -4.76%-6.52% | -5.68%-5.52% | -5.19%-7.12% | +21.07%+19.22% | +18.57%+26.51% | -23.52%+1.84% |
| Flows | HTEC PBE | --$3M | -+$969K | -+$135K | -$4M-$32M | -$60M-$56M | -$82M-$39M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | HTEC PBE | +16.61%+18.95% | +21.87%+22.28% | +19.84%+20.18% | +23.75%+22.77% |
| Max drawdown | HTEC PBE | -11.97%-11.05% | -15.36%-16.18% | -28.61%-22.21% | -56.05%-34.74% |
| Max drawdown duration | HTEC PBE | 48d65d | 99d107d | 546d324d | 1651d1540d |
HTEC | PBE | |
Last sale 3/13/2026 at 1:30 PM | $32.36 | $76.18 |
| Previous close 03/12/2026 | $32.41 | $76.18 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
HTEC | PBE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
HTEC | PBE | |
|---|---|---|
| Last price | $32.36 | $76.18 |
| 1D performance | -0.15% | +0.00% |
| AuM | $50.42 M | $240.98 M |
| E/R | 0.8% | 0.58% |
HTEC | PBE | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | ROBO Global ETFs | Invesco |
| Benchmark | ROBO Global Healthcare Technology and Innovation | Dynamic Biotech & Genome Intellidex Index |
| N° of holdings | 58 | 30 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 25, 2019 | June 23, 2005 |
| ESG | Yes | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
